CN111905087A - Health-care product composition for dispelling effects of alcohol and protecting liver - Google Patents
Health-care product composition for dispelling effects of alcohol and protecting liver Download PDFInfo
- Publication number
- CN111905087A CN111905087A CN202010822363.9A CN202010822363A CN111905087A CN 111905087 A CN111905087 A CN 111905087A CN 202010822363 A CN202010822363 A CN 202010822363A CN 111905087 A CN111905087 A CN 111905087A
- Authority
- CN
- China
- Prior art keywords
- liver
- alcohol
- care product
- amomum
- chrysanthemum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract description 41
- 239000000203 mixture Substances 0.000 title abstract description 6
- 230000000694 effects Effects 0.000 title description 18
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 20
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 18
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 18
- 241001127714 Amomum Species 0.000 claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 17
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 235000012907 honey Nutrition 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 4
- 244000179886 Moringa oleifera Species 0.000 claims abstract 5
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 3
- 244000269722 Thea sinensis Species 0.000 claims abstract 3
- 206010019133 Hangover Diseases 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 9
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 4
- 235000000228 Citrus myrtifolia Nutrition 0.000 claims description 4
- 235000016646 Citrus taiwanica Nutrition 0.000 claims description 4
- 241000723353 Chrysanthemum Species 0.000 claims 4
- 244000183685 Citrus aurantium Species 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 17
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 11
- BFBPISPWJZMWJN-UHFFFAOYSA-N methyl 2-[(7-hydroxy-3,7-dimethyloctylidene)amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N=CCC(C)CCCC(C)(C)O BFBPISPWJZMWJN-UHFFFAOYSA-N 0.000 abstract description 11
- 208000007848 Alcoholism Diseases 0.000 abstract description 6
- 201000007930 alcohol dependence Diseases 0.000 abstract description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 239000012528 membrane Substances 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 230000007059 acute toxicity Effects 0.000 abstract description 4
- 231100000403 acute toxicity Toxicity 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 210000005229 liver cell Anatomy 0.000 abstract description 4
- 230000002075 anti-alcohol Effects 0.000 abstract description 3
- 235000019441 ethanol Nutrition 0.000 description 25
- 241001122767 Theaceae Species 0.000 description 23
- 210000000952 spleen Anatomy 0.000 description 19
- 241000220215 Moringa Species 0.000 description 15
- 240000004371 Panax ginseng Species 0.000 description 11
- 241000234314 Zingiber Species 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 208000013220 shortness of breath Diseases 0.000 description 4
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 4
- 240000003791 Citrus myrtifolia Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 244000197580 Poria cocos Species 0.000 description 3
- 235000008599 Poria cocos Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 229960000278 theophylline Drugs 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010034568 Peripheral coldness Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- QTVAYNGFFDZGDR-CIJVEFAYSA-N 5-hydroxy-6-methoxy-3-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)O3)O)=C(OC)C(O)=C2C1=O QTVAYNGFFDZGDR-CIJVEFAYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010001605 Alcohol poisoning Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000007495 abnormal renal function Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000004149 ethanol metabolism Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- -1 hydroxyethyl group Chemical group 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- MYJXWCIZOOKQLK-UHFFFAOYSA-N kakkalide Natural products COc1cc2C(=O)C(=COc2cc1OC3OC(COC4OCC(O)C(O)C4O)C(O)C(O)C3O)c5ccc(O)cc5 MYJXWCIZOOKQLK-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种既能够提高机体中的抗氧化能力,有效清除酒精代谢产生的自由基和缓解肝细胞膜表面的脂质成分过度氧化,预防酒精急性毒性的解酒保肝养生保健品组方,重量份:250ml液体中含有茶多酚280~320mg,辣木籽1.8~2.2g,葛花1.8~2.2g,枳椇子2~3g,蜂蜜12~17g,干姜0.8~1.2g,人参1.8~2.2g,茯苓2.8~3.2g,橘皮2.8~3.2g,麦芽2.8~3.2g,砂仁1.8~2.2g,菊花0.8~1.2g。优点:能有效缓解醉酒症状,防止酒精中毒,保肝护胃。The invention relates to an anti-alcoholic, liver-protecting and health-care product composition which can improve the antioxidant capacity in the body, effectively remove free radicals generated by alcohol metabolism, relieve the excessive oxidation of lipid components on the surface of liver cell membranes, and prevent the acute toxicity of alcohol. Servings: 250ml of liquid contains 280~320mg of tea polyphenols, 1.8~2.2g of Moringa seeds, 1.8~2.2g of kudzu flowers, 2~3g of aurantium seeds, 12~17g of honey, 0.8~1.2g of dried ginger, 1.8~1.2g of ginseng 2.2g, Poria 2.8~3.2g, orange peel 2.8~3.2g, malt 2.8~3.2g, Amomum 1.8~2.2g, chrysanthemum 0.8~1.2g. Advantages: It can effectively relieve the symptoms of drunkenness, prevent alcoholism, and protect the liver and stomach.
Description
技术领域technical field
本发明涉及一种既能够提高机体中的抗氧化能力,有效清除酒精代谢产生的自由基和缓解肝细胞膜表面的脂质成分过度氧化,预防酒精急性毒性的解酒保肝养生保健品组方,属保健饮品制造领域。The invention relates to an anti-alcoholic and liver-protecting health-care product composition which can improve the antioxidant capacity in the body, effectively remove free radicals generated by alcohol metabolism, alleviate the excessive oxidation of lipid components on the surface of liver cell membranes, and prevent the acute toxicity of alcohol. Health drink manufacturing field.
背景技术Background technique
CN102845663 B、名称“一种具有保肝解酒功能的保健品组合物”,其特征在于,由枳椇子提取物10~15重量份,葛根提取物5~10 重量份,枸杞提取物 1~2 重量份,大枣提取物 2~4 重量份,茯苓提取物 1~2 重量份,干姜提取物 0.5~1 重量份,糖 40~60 重量份和酸味剂 1~5 重量份以及粘合剂组成。该保健品含多种中药材中的有效成分,具有疏肝理气、健脾消食、降低转氨酶的功效,解酒功能,对酒精造成的肝细胞损伤还具有一定的修复作用。其不足之处:虽然具有缓解解酒功能,但效果不明显。CN102845663 B. Name "a health care product composition with the function of protecting liver and detoxifying", which is characterized in that 10-15 parts by weight of Citrus aurantium extract, 5-10 parts by weight of Pueraria lobata extract, 1-10 parts by weight of Lycium barbarum extract 2 parts by weight, 2-4 parts by weight of jujube extract, 1-2 parts by weight of Poria cocos extract, 0.5-1 part by weight of dried ginger extract, 40-60 parts by weight of sugar, 1-5 parts by weight of acidulant and binding agent agent composition. The health care product contains active ingredients in a variety of Chinese medicinal materials, and has the functions of soothing the liver and regulating qi, strengthening the spleen and digesting food, reducing transaminase, and relieving alcohol. It also has a certain repairing effect on liver cell damage caused by alcohol. Its shortcomings: Although it has the function of relieving hangover, the effect is not obvious.
发明内容SUMMARY OF THE INVENTION
设计的目的:避免背景技术中的不足之处,设计一种既能够提高机体中的抗氧化能力,有效清除酒精代谢产生的自由基和缓解肝细胞膜表面的脂质成分过度氧化,预防酒精急性毒性的解酒保肝养生保健品组方。The purpose of the design: to avoid the deficiencies in the background technology, to design a method that can not only improve the antioxidant capacity in the body, effectively remove the free radicals generated by alcohol metabolism, relieve the excessive oxidation of lipid components on the surface of the liver cell membrane, and prevent the acute toxicity of alcohol. The prescription of hangover and liver protection health care products.
设计方案:为了实现上述设计目的。本发明在保健器的组方上,主要成分含有茶多酚、辣木籽、葛花、枳椇子、蜂蜜、干姜、人参、茯苓、橘皮、麦芽、砂仁、菊花共含12味成分,能有效缓解醉酒症状,防止酒精中毒,达到保肝护胃的目的。Design scheme: In order to achieve the above design purpose. In the formulation of the health-care device, the main components of the present invention contain tea polyphenols, moringa seeds, kudzu flowers, aurantium seeds, honey, dried ginger, ginseng, poria, orange peel, malt, Amomum, and chrysanthemum, which contain 12 flavors in total. It can effectively relieve the symptoms of drunkenness, prevent alcoholism, and achieve the purpose of protecting the liver and stomach.
1、茶多酚:1. Tea polyphenols:
日常生活中,人们常常在醉酒之后以浓茶来解酒。这里解酒的主要成分就是茶多酚。在三国魏人张揖所作《广雅》中:“饼茶捣末,置瓷器中,以汤浇覆之,用葱、姜、橘子芼之。其饮醒酒,令人不眠。”In daily life, people often drink strong tea to hangover after getting drunk. The main component of hangover here is tea polyphenols. In the "Guang Ya" written by Zhang Yi of the Wei Dynasty of the Three Kingdoms: "The cake and tea are pounded to the end, placed in the porcelain, covered with soup, and spiced with green onions, ginger, and oranges. Drinking sobers makes people sleepless."
现代许多中医学者和茶叶专家,都从不同角度阐述了茶能解酒。著名的毛连根研究员认为:茶的提取物(茶多酚)具有醒酒作用,能促进实验中小白鼠的乙醇代谢。然而实验表明,酒后饮茶,茶中的茶碱具有兴奋心脏的作用,酒精也对心脏有很大的兴奋作用,两种物质同时作用,会加重心脏的负担。除此之外,茶中的茶碱会刺激肾脏加速利尿作用,由于排水过速,会把来不及完全氧化分解的乙醛提早引入肾脏。所以,将茶叶中解酒的核心元素——茶多酚提取出来,而剔除掉茶碱等元素,便能更加安全有效的解酒,而无其他副作用。Many modern Chinese medicine scholars and tea experts have explained that tea can relieve hangover from different angles. The well-known researcher of Mao Liangen believes that the tea extract (tea polyphenols) has the effect of sobering up and can promote the ethanol metabolism of the mice in the experiment. However, experiments have shown that drinking tea after drinking, theophylline in tea has the effect of stimulating the heart, and alcohol also has a great stimulating effect on the heart. The simultaneous action of the two substances will increase the burden on the heart. In addition, theophylline in tea will stimulate the kidneys to accelerate the diuretic effect. Due to excessive drainage, the acetaldehyde that is too late for complete oxidative decomposition will be introduced into the kidneys earlier. Therefore, extracting tea polyphenols, the core element of hangover in tea, and removing elements such as theophylline, can more safely and effectively hangover without other side effects.
茶多酚不仅有醒酒作用,还能预防酒精急性毒性作用。肝脏是体内酒精代谢的主要场所,少量的酒精在肝细胞浆的乙醇脱氢酶作用下经双电子还原为乙醛,乙醛的化学性质非常活泼,它可干扰蛋白质分子(尤其是酶)的修饰与激活。乙醇还可经复杂的单电子链式反应还原为羟乙基,继而攻击膜上的多不饱和脂肪酸而引起膜脂质过氧化。茶多酚作为抗氧化剂,既可抑制乙醇氧化为乙醛,也可清除机体内由乙醇介导的氧化应激产生的自由基,这对减缓酒精性肝病患者症状的护肝作用。Tea polyphenols not only have a sobering effect, but also prevent the acute toxicity of alcohol. The liver is the main site of alcohol metabolism in the body. A small amount of alcohol is reduced to acetaldehyde by two electrons under the action of alcohol dehydrogenase in the liver cytoplasm. Modification and activation. Ethanol can also be reduced to hydroxyethyl group by a complex one-electron chain reaction, and then attack the polyunsaturated fatty acids on the membrane to cause membrane lipid peroxidation. As an antioxidant, tea polyphenols can not only inhibit the oxidation of ethanol to acetaldehyde, but also scavenge free radicals generated by ethanol-mediated oxidative stress in the body, which has a liver-protective effect on alleviating the symptoms of patients with alcoholic liver disease.
2、辣木籽:2. Moringa seeds:
辣木籽是一种天然植物,是近几年大家研究的非常多的一类新兴的食材,并且已经被我们国家列入到药食同源相关的这种食材之中。辣木籽中丰富的果糖,VC,蛋白质等成分,可以为肝脏解酒提供足够的能力,防治喝酒后肝脏因为解酒产生损伤。其活性成分可以有效的帮助肝脏分泌解酒酶,从而使酒精快速散发,通过尿液以及呼吸快速的排出体外,并且辣木籽可以有效针对酒精保护胃部。除此之外辣木籽其具备非常高的黄酮类,有很强的抗氧化和增强免疫能力的作用,有利于代谢甘精胰岛素和调整血糖值,长期服用针对降高血压、降高血脂、降高血糖有显著实际效果,能够防止癌症、预防肿瘤、提高免疫力、维护心脏、治疗糖尿病,还能改善男性的生育能力。Moringa seed is a kind of natural plant. It is a new type of food material that has been studied by many people in recent years, and has been included in our country as one of the food materials related to the same origin of medicine and food. Moringa seeds are rich in fructose, VC, protein and other ingredients, which can provide enough ability for the liver to hangover and prevent liver damage caused by hangover after drinking. Its active ingredients can effectively help the liver to secrete hangover enzymes, so that alcohol can be quickly dissipated and excreted quickly through urine and breathing, and Moringa seeds can effectively protect the stomach against alcohol. In addition, Moringa seeds have very high flavonoids, which have strong antioxidant and immune-enhancing effects, which are beneficial to metabolize insulin glargine and adjust blood sugar levels. Lowering blood sugar has significant practical effects, preventing cancer, preventing tumors, improving immunity, protecting the heart, treating diabetes, and improving male fertility.
3、葛花:3. Gehua:
据《兰室秘藏》记载,葛花解汤酲具有化酒祛湿,温中和胃的功效。其中,葛花为解酒专药。《本草纲目》中记载,葛根能清热祛火,生津止渴,解酒醒脾,使酒湿从肌表而散。1975年,科学家首次从葛花中分离得到了一种新的异黄酮普,命名为 Kakkalide。研究发现,异黄酮普可降低酒精中毒引起的小鼠死亡率,并可对抗酒精引起的大鼠转氨酶升高,提示异黄酮普对酒精中毒和酒精性肝损伤具有治疗和缓解作用。According to the "Orchid House Secret Collection", Gehua Jie Tang has the effect of dissolving wine and removing dampness, warming and neutralizing the stomach. Among them, Gehua is a special medicine for hangover. According to "Compendium of Materia Medica", Pueraria lobata can clear heat and dispel fire, promote body fluid and quench thirst, relieve hangover and sober up the spleen, and make alcohol-dampness disperse from the muscle surface. In 1975, scientists isolated a new isoflavone from Pueraria for the first time, named Kakkalide. Studies have found that isoflavones can reduce the mortality of mice caused by alcoholism, and can resist the increase of transaminases caused by alcohol in rats, suggesting that isoflavones have therapeutic and relieving effects on alcoholism and alcoholic liver damage.
有研究人员在常规西医治疗基础上加用葛花茶治疗急性重症酒精中毒,并与常规西医治疗组相比较。临床疗效表明,加用葛花治疗可以减少上消化道出血、肾功能异常及肝功能异常的发生率,并能有效缓解酒后引起的头痛、头晕、无力、恶心及震颤等症状。Some researchers added Gehua tea to treat acute severe alcoholism on the basis of conventional western medicine treatment, and compared it with the conventional western medicine treatment group. The clinical efficacy shows that the addition of Gehua can reduce the incidence of upper gastrointestinal bleeding, abnormal renal function and abnormal liver function, and can effectively relieve symptoms such as headache, dizziness, weakness, nausea and tremor caused by drinking.
4、枳椇子:4. Citrus aurantium:
枳椇,性平,味甘;归胃经。有止渴除烦、清湿热、解酒毒的功效。可以用来治疗水肿症,酒醉。枳椇子中的葡萄糖、苹果酸钙,有较强的利尿作用,能促进乙醇的分解和排出,显著降低乙醇在血液中的浓度,并能消除乙醇在体内产生的自由基,阻止过氧化酯质的形成,从而减轻乙醇对肝组织的损伤,避免酒精中毒导致各种代谢异常,诱发各种疾病。此外,枳椇子还是消化人体过多脂肪的保健果品,常吃可以减肥健美。Citrus aurantium, flat in nature, sweet in taste; it belongs to the stomach meridian. It has the effect of quenching thirst and removing vexation, clearing dampness and heat, and detoxifying. Can be used to treat edema, drunkenness. Glucose and calcium malate in Fructus Aurantium have strong diuretic effects, can promote the decomposition and excretion of ethanol, significantly reduce the concentration of ethanol in the blood, and can eliminate the free radicals produced by ethanol in the body and prevent peroxyesters. Therefore, it can reduce the damage of ethanol to liver tissue, and avoid various metabolic abnormalities caused by alcoholism and induce various diseases. In addition, Fructus Aurantii is also a health-care fruit for digesting excess fat in the human body. Eating it often can help you lose weight and get fit.
5、蜂蜜:5. Honey:
蜂蜜味甘,性平;归肺、脾、大肠经。具有补中缓急,润肺止咳,润肠通便的功效。Honey is sweet in taste and flat in nature; it belongs to the lung, spleen and large intestine meridians. It has the effects of invigorating the middle and urgent, moistening the lungs and relieving cough, and moistening the bowels.
主要用于脾胃虚弱,脘腹作痛,肺燥干咳,肺虚久咳,肠燥便秘等。蜂蜜中的特殊果糖,可有效分解和吸收酒精,从而起到快速醒酒的作用,消除酒后头痛、头晕现象。It is mainly used for weak spleen and stomach, abdominal pain, dry cough due to lung dryness, chronic cough due to lung deficiency, constipation due to intestinal dryness, etc. The special fructose in honey can effectively decompose and absorb alcohol, so as to quickly sober up and eliminate the phenomenon of headache and dizziness after drinking.
6、干姜:6. Ginger:
干姜味辛,性热;归脾、胃、心,肺经。具有祛风除湿,温中散寒的功效。它含有挥发油,姜酮,姜醇,姜烯酮等物质。可用于治疗伤寒,鼻塞,气喘,咳嗽,呕吐,痢疾,腹泻,水肿,胀气,手脚肢冷,胸闷,气短等症。Dried ginger is pungent and hot in nature; it returns to the spleen, stomach, heart and lung meridians. It has the effect of dispelling wind and dampness, warming the middle and dispelling cold. It contains volatile oils, zingerone, gingerol, zingerone and other substances. It can be used to treat typhoid fever, nasal congestion, asthma, cough, vomiting, dysentery, diarrhea, edema, flatulence, cold hands and feet, chest tightness, and shortness of breath.
7、人参:7. Ginseng:
人参味甘、微苦,性微温,归脾、肺经,具有补气救脱,补益脾肺,生津止渴,安神益智的作用。可用于大病久病、大失血或剧烈吐泻后,治疗气短神疲,脉微欲绝。也可用于治疗脾胃气虚,神疲乏力,气短食少,上腹痞满,腹泻日久及各种原因的气虚气弱。还可用于治疗肺虚咳喘,气短乏力,咳嗽声弱。人参具有鼓舞脾胃元气,以输布津液而达到止渴作用,可用于津伤口渴和消渴症,也可用于治疗心脾不足所导致的心悸怔肿,失眠健忘。Ginseng is sweet, slightly bitter, slightly warm in nature, and returns to the spleen and lung meridians. It can be used for the treatment of shortness of breath, exhaustion and faint pulse after severe illness, prolonged illness, massive blood loss or severe vomiting and diarrhea. It can also be used to treat spleen and stomach qi deficiency, mental fatigue, shortness of breath, lack of appetite, epigastric fullness, prolonged diarrhea and various causes of qi deficiency and qi weakness. It can also be used to treat lung deficiency, cough and asthma, shortness of breath, fatigue, and weak cough. Ginseng can stimulate the vitality of the spleen and stomach, and can quench thirst by infusing body fluids.
8、茯苓:8. Poria:
茯苓味甘、淡,性平;归心、肺、脾、肾经。利水消肿,渗湿,健脾,宁心。主要用于小便不利、水肿胀满、呕吐、脾胃虚弱而饮食减少,腹泻,心气虚弱引起的心悸不安、失眠健忘等症状的治疗。Poria is sweet, light, and neutral in nature; it returns to the heart, lung, spleen, and kidney meridians. Dilutes water to reduce swelling, infiltrates dampness, invigorates the spleen, and calms the heart. It is mainly used for the treatment of dysuria, edema, vomiting, weak spleen and stomach and reduced diet, diarrhea, palpitations, restlessness, insomnia and forgetfulness caused by weak heart qi.
9、橘皮:9. Orange peel:
皮味辛、苦,性温;归脾、肺经。有理气健脾,燥湿化痰之功效。主治脾胃气滞症,呕吐、呃逆,湿痰、寒痰咳嗽。The skin is pungent, bitter, and warm in nature; it returns to the spleen and lung meridians. It has the effect of regulating Qi and strengthening the spleen, drying dampness and resolving phlegm. Indications of spleen and stomach qi stagnation, vomiting, hiccups, cough with damp phlegm and cold phlegm.
10、麦芽:10. Malt:
味甘,性平;归脾、胃、肝经。具有消食健胃,回乳消胀的功效。可以疏肝解郁,治疗Sweet in taste, flat in nature; return to the spleen, stomach and liver meridians. It has the effect of digesting food and strengthening the stomach, returning milk and reducing bloating. Can soothe the liver and relieve depression, treat
米面薯芋食滞,断乳、乳房胀痛:本品有回乳之功。Rice noodles, potatoes, taro, food stagnation, weaning, breast pain: this product has the power to restore milk.
11、砂仁:11. Amomum:
砂仁味辛,温;归脾、胃、肾经。具有化湿行气,温中止泻,安胎的功效。主治脾胃气滞、湿阻中焦,脾胃虚寒、呕吐泻泄,胎动不安、妊娠恶阻等。Amomum glutinosa is pungent and warm; it returns to the spleen, stomach and kidney meridians. It has the functions of dissolving dampness and promoting qi, stopping diarrhea and preventing fetuses. Indications: Qi stagnation in the spleen and stomach, dampness in the middle Jiao, deficiency of the spleen and stomach, vomiting and diarrhea, restless fetal movement, and obstructive pregnancy.
12、菊花:12. Chrysanthemum:
菊花味辛、甘、苦,性微寒;归肺、肝经。具有疏散风热,平抑肝阳,清肝明目,清热解毒的功效。主治风热感冒,温病初起,肝阳眩晕,肝风实证,目赤昏花,疮痈肿毒。Chrysanthemum is acrid, sweet and bitter in taste, slightly cold in nature; it belongs to the lung and liver meridians. It has the effects of dispersing wind-heat, calming liver-yang, clearing liver and improving eyesight, clearing heat and detoxifying. Indications: Wind-heat cold, early onset of febrile disease, liver-yang dizziness, liver-wind syndrome, red eyes and dim vision, sore carbuncle swollen poison.
将上述12味成分构成的保健品,其茶多酚提高了机体中的抗氧化能力,有效清除酒精代谢产生的自由基和缓解肝细胞膜表面的脂质成分的过度氧化,预防酒精急性毒性;葛花可作为肠胃的吸收抑制剂,抑制酒精的肠胃吸收,保护肠胃;辣木籽中丰富的黄酮类物质可明显诱导提高肝内酶的活性,加强酒精及其代谢物的消除速率;而余下的其它中药成分具有健脾化湿、消食化痰、清热解毒、开窍醒神、生津止渴、行气化积的功效,调和饮酒后脘腹胀闷、痰多、眩晕呕吐、口渴欲饮、胁肋胀痛、面目黄肿等症状。The health care product composed of the above 12 ingredients, its tea polyphenols improve the antioxidant capacity in the body, effectively remove free radicals generated by alcohol metabolism and relieve the excessive oxidation of lipid components on the surface of liver cell membranes, preventing acute alcohol toxicity; Flowers can be used as gastrointestinal absorption inhibitors, inhibit the gastrointestinal absorption of alcohol, and protect the gastrointestinal Other traditional Chinese medicine ingredients have the functions of invigorating the spleen and removing dampness, eliminating food and phlegm, clearing away heat and detoxifying, opening the orifices and refreshing the mind, promoting fluid and quenching thirst, promoting qi and transforming accumulation, and reconciling abdominal distention and stuffiness after drinking alcohol, excessive phlegm, dizziness and vomiting, thirst, desire to drink, and flank. Symptoms such as rib pain, facial yellowing and swelling.
技术方案:一种解酒保肝养生保健品组方,重量份:250ml液体中含有茶多酚280~320mg,辣木籽1.8~2.2g,葛花1.8~2.2g,枳椇子2~3g,蜂蜜12~17g,干姜0.8~1.2g,人参1.8~2.2g,茯苓2.8~3.2g,橘皮2.8~3.2g,麦芽2.8~3.2g,砂仁1.8~2.2g,菊花0.8~1.2g。Technical scheme: a prescription for a hangover, liver and health care product, in parts by weight: 250 ml of liquid contains 280-320 mg of tea polyphenols, 1.8-2.2 g of Moringa seeds, 1.8-2.2 g of kudzu flowers, and 2-3 g of Fructus aurantium seeds, Honey 12~17g, dried ginger 0.8~1.2g, ginseng 1.8~2.2g, Poria 2.8~3.2g, orange peel 2.8~3.2g, malt 2.8~3.2g, Amomum 1.8~2.2g, chrysanthemum 0.8~1.2g.
本发明与背景技术相比,能有效缓解醉酒症状,防止酒精中毒,保肝护胃,与目前市场销保的解酒保健产品相比,其采用小白鼠对比,其状态如下:Compared with the background technology, the present invention can effectively relieve the symptoms of drunkenness, prevent alcohol poisoning, protect the liver and stomach, and compare with the currently marketed anti-alcohol health care products, which are compared with mice, and their states are as follows:
具体实施方式Detailed ways
实施例1:一种解酒保肝养生保健品组方,其特征是重量份:250ml液体中含有茶多酚280~320mg,辣木籽1.8~2.2g,葛花1.8~2.2g,枳椇子2~3g,蜂蜜12~17g,干姜0.8~1.2g,人参1.8~2.2g,茯苓2.8~3.2g,橘皮2.8~3.2g,麦芽2.8~3.2g,砂仁1.8~2.2g,菊花0.8~1.2g,并且按水量的多少,其上述的12种成分同比例放大或缩小,并且可以在12种成分取量的范围内任意选值且包括端值进行组方。Embodiment 1: a kind of prescription of hangover and liver health-preserving health care product, it is characterized in that parts by weight: 250ml liquid contains 280~320mg of tea polyphenols, 1.8~2.2g of Moringa seeds, 1.8~2.2g of kudzu flowers, Fructus Aurantii 2~3g, honey 12~17g, dried ginger 0.8~1.2g, ginseng 1.8~2.2g, tuckahoe 2.8~3.2g, orange peel 2.8~3.2g, malt 2.8~3.2g, Amomum 1.8~2.2g, chrysanthemum 0.8 ~1.2g, and according to the amount of water, the above-mentioned 12 components are enlarged or reduced in the same proportion, and the value can be arbitrarily selected within the range of the 12 components including the end value for formulating.
本发明中的辣木籽、葛花、枳椇子、橘皮、麦芽、砂仁、菊花是指辣木籽、葛花、枳椇子、橘皮、麦芽、砂仁、菊花是指食用萃取提取物。所述的食用萃取是指采用食用级卫生设备对上述12种成分进行萃取,其方法系公知技术,在此不作叙述。In the present invention, moringa seeds, kudzu flowers, aurantium seeds, orange peel, malt, amomum, chrysanthemum refer to moringa seeds, kudzu flowers, aurantium seeds, orange peel, malt, amomum, chrysanthemum refers to edible extracts Extract. The edible extraction refers to the extraction of the above 12 components by using food-grade sanitary equipment, and the method is a well-known technology, which will not be described here.
实施例2:在实施例1的基础上,250ml液体中含有茶多酚300mg,辣木籽2g,葛花2g,枳椇子2~3g,蜂蜜15g,干姜1g,人参2g,茯苓3g,橘皮3g,麦芽3g,砂仁2g,菊花1g。Example 2: On the basis of Example 1, 250ml of liquid contains 300mg of tea polyphenols, 2g of Moringa seeds, 2g of kudzu flowers, 2~3g of Fructus aurantium, 15g of honey, 1g of dried ginger, 2g of ginseng, 3g of Poria cocos, Orange peel 3g, malt 3g, Amomum 2g, chrysanthemum 1g.
实施例3:在实施例1的基础上,250ml液体中含有茶多酚280mg,辣木籽1.8g,葛花1.8g,枳椇子2g,蜂蜜12g,干姜0.8g,人参1.8g,茯苓2.8g,橘皮2.8g,麦芽2.8g,砂仁1.8g,菊花0.8g。Example 3: On the basis of Example 1, 250ml of liquid contains 280mg of tea polyphenols, 1.8g of Moringa seeds, 1.8g of kudzu, 2g of Fructus aurantium, 12g of honey, 0.8g of dried ginger, 1.8g of ginseng, and Poria 2.8g, orange peel 2.8g, malt 2.8g, Amomum 1.8g, chrysanthemum 0.8g.
实施例4:在实施例1的基础上,250ml液体中含有茶多酚320mg,辣木籽2.2g,葛花2.2g,枳椇子3g,蜂蜜17g,干姜1.2g,人参12.2g,茯苓3.2g,橘皮3.2g,麦芽3.2g,砂仁2.2g,菊花1.2g。Example 4: On the basis of Example 1, 250ml of liquid contained 320mg of tea polyphenols, 2.2g of Moringa seeds, 2.2g of kudzu flowers, 3g of Fructus aurantium, 17g of honey, 1.2g of dried ginger, 12.2g of ginseng, and Poria 3.2g, orange peel 3.2g, malt 3.2g, Amomum 2.2g, chrysanthemum 1.2g.
实施例5:在实施例1的基础上,250ml液体中含有茶多酚290mg,辣木籽1.9g,葛花1.9g,枳椇子2.3g,蜂蜜124g,干姜0.9g,人参1.9g,茯苓2.9g,橘皮2.9g,麦芽2.9g,砂仁1.9g,菊花0.9g。Example 5: On the basis of Example 1, 250ml of the liquid contained 290mg of tea polyphenols, 1.9g of Moringa seeds, 1.9g of kudzu, 2.3g of Fructus aurantium, 124g of honey, 0.9g of dried ginger, 1.9g of ginseng, Poria 2.9g, orange peel 2.9g, malt 2.9g, Amomum 1.9g, chrysanthemum 0.9g.
实施例6:在实施例1的基础上,250ml液体中含有茶多酚300mg,辣木籽2.1g,葛花2.1g,枳椇子2.9g,蜂蜜16g,干姜1.1g,人参1.9g,茯苓3.0g,橘皮3.0g,麦芽3.1g,砂仁2.1g,菊花1.1g。Example 6: On the basis of Example 1, 250ml of liquid contained 300mg of tea polyphenols, 2.1g of Moringa seeds, 2.1g of kudzu flowers, 2.9g of Fructus aurantium, 16g of honey, 1.1g of dried ginger, 1.9g of ginseng, Poria 3.0g, orange peel 3.0g, malt 3.1g, Amomum 2.1g, chrysanthemum 1.1g.
需要理解到的是:上述实施例虽然对本发明的设计思路作了比较详细的文字描述,但是这些文字描述,只是对本发明设计思路的简单文字描述,而不是对本发明设计思路的限制,任何不超出本发明设计思路的组合、增加或修改,均落入本发明的保护范围内。It should be understood that: although the above-mentioned embodiments have made a more detailed description of the design ideas of the present invention, these text descriptions are only simple text descriptions of the design ideas of the present invention, rather than restrictions on the design ideas of the present invention. The combination, addition or modification of the design ideas of the present invention all fall within the protection scope of the present invention.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010822363.9A CN111905087A (en) | 2020-08-17 | 2020-08-17 | Health-care product composition for dispelling effects of alcohol and protecting liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010822363.9A CN111905087A (en) | 2020-08-17 | 2020-08-17 | Health-care product composition for dispelling effects of alcohol and protecting liver |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111905087A true CN111905087A (en) | 2020-11-10 |
Family
ID=73278065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010822363.9A Pending CN111905087A (en) | 2020-08-17 | 2020-08-17 | Health-care product composition for dispelling effects of alcohol and protecting liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111905087A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113647483A (en) * | 2021-08-25 | 2021-11-16 | 陕西芼茶缘文化传播有限公司 | Process for making tea |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1369275A (en) * | 2001-02-17 | 2002-09-18 | 章军民 | Sobering-up agent |
-
2020
- 2020-08-17 CN CN202010822363.9A patent/CN111905087A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1369275A (en) * | 2001-02-17 | 2002-09-18 | 章军民 | Sobering-up agent |
Non-Patent Citations (4)
| Title |
|---|
| 刘基柱: "《中草药识别与应用.下册》", 31 August 2011, 广东人民出版社 * |
| 王唯: "《健康食用主义》", 30 April 2009, 江西科学技术出版社 * |
| 赖来展,等: "《黑色食品与健康长寿》", 31 October 2014, 金盾出版社 * |
| 郭旭光: "解酒醒酒有良方", 《家庭医学》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113647483A (en) * | 2021-08-25 | 2021-11-16 | 陕西芼茶缘文化传播有限公司 | Process for making tea |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
| CN104531477A (en) | Peony kidney-nourishing wine and preparation method thereof | |
| CN105233119A (en) | Traditional Chinese medicine composition enhancing body immunity of middle-aged and aged people and preparation method thereof | |
| CN102205107A (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
| CN102205108A (en) | Traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof | |
| CN103736072B (en) | Medicine of a kind for the treatment of of allergic rhinitis and preparation method thereof | |
| CN105831543A (en) | Chrysanthemum health beverage with effects of calming liver and improving eyesight and preparation method thereof | |
| CN114651968A (en) | Hangover alleviating composition formula and preparation method thereof | |
| CN111905087A (en) | Health-care product composition for dispelling effects of alcohol and protecting liver | |
| CN106509209A (en) | Propolis health-care tea and preparation method thereof | |
| CN104082670B (en) | A kind of health porridge with blood pressure lowering effect and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN114767826A (en) | Sobering-up and liver-protecting composition, beverage with sobering-up and liver-protecting effects and preparation method of beverage | |
| CN106822660A (en) | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease | |
| CN104324229A (en) | Composition for relieving fatigue and preparation and application of composition | |
| CN104606571A (en) | Fresh spinach root tea substituted drink with effects of helping produce saliva and slaking thirst and preparation method thereof | |
| CN111513163A (en) | Clear reed rhizome tea for conditioning damp-heat constitution and preparation method thereof | |
| CN110558409A (en) | A Chinese medicinal health tea with anti-hangover effect, and its preparation method | |
| CN115607629B (en) | A traditional Chinese medicine composition capable of protecting liver and relieving alcoholism and preparation method thereof | |
| CN107183426A (en) | A kind of liver-protecting sobering up plant beverage, preparation method and the usage | |
| CN103638468B (en) | Medicament for treating favism and preparation method thereof | |
| CN105561192A (en) | Cordyceps sinensis and fructus hippophae healthy medicinal liquor | |
| CN105362940A (en) | Hypolipidemic cholesterol-reducing healthcare oral solution and preparation method thereof | |
| CN114887012A (en) | Clove stomach-invigorating paste and preparation method thereof | |
| CN113057317A (en) | Split ointment formula suitable for diabetes and high risk group thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201110 |
